Vybrique is expected to be available in March 2026, with a direct to home delivery option being available to all states. The Food and Drug Administration (FDA) has approved Vybrique ™ (sildenafil) ...
OpenAI is releasing a new app called Prism today, and it hopes it does for science what coding agents like Claude Code and its own Codex platform have done for programming. Prism builds on Crixet, a ...
The U.S. Food and Drug Administration (FDA) said it is aware that Boston Scientific Corporation (NYSE: BSX) has alerted customers to remove certain AXIOS stents and electrocautery-enhanced delivery ...
The FDA has updated guidance outlining how it applies regulatory flexibility to chemistry, manufacturing and control requirements for cell and gene therapies. The agency said the approach is meant to ...
W.L. Gore & Associates has received FDA approval for the Gore Viabahn Fortegra Venous Stent — the first device indicated to treat deep venous disease in the inferior vena cava, as well as the iliac ...
The gray-market drugs flooding Silicon Valley reveal a community that believes it can move faster than the F.D.A. Credit...Hannah Agosta Supported by By Jasmine Sun Jayden Clark first heard about ...
The native just-in-time compiler in Python 3.15 can speed up code by as much as 20% or more, although it’s still experimental. JITing, or “just-in-time” compilation, can make relatively slow ...
Novo Nordisk wins FDA approval for Wegovy in a pill, introducing first oral GLP-1 option for obesity
After ushering in a new era of obesity treatment with its GLP-1 medicine Wegovy earlier in the decade, Novo Nordisk is making history again with the first FDA approval of a GLP-1 pill for weight loss.
Share on Pinterest Addyi, sometimes referred to as “female Viagra,” is now approved for use to treat low sex drive in postmenopausal women. MoMo Productions/Getty Images The FDA expanded its approval ...
The U.S. Food and Drug Administration is reportedly weighing whether it will place a “black box” warning label on COVID vaccines, according to CNN, despite research and real-world data demonstrating ...
A Food and Drug Administration panel on Wednesday advocated for regulatory changes that would make testosterone medications more widely accessible, including removing their classification as ...
U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results